Core Viewpoint - Amprius Technologies (AMPX) is expected to report a year-over-year decline in earnings despite higher revenues, with the earnings report set for March 21, 2024 [1] Revenue and Earnings Estimates - The company is projected to post a quarterly loss of $0.12 per share, reflecting a year-over-year change of -71.4% [2] - Revenues are anticipated to reach $2.6 million, representing a significant increase of 229.1% from the same quarter last year [2] Estimate Revisions - The consensus EPS estimate has been revised 4.35% higher in the last 30 days, indicating a reassessment by covering analysts [2] - The Most Accurate Estimate for Amprius is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +16.67% [5] Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [4] - Amprius currently holds a Zacks Rank of 3, suggesting a likelihood of beating the consensus EPS estimate [6] Historical Performance - In the last reported quarter, Amprius was expected to post a loss of $0.13 per share but actually reported a loss of $0.10, achieving a surprise of +23.08% [7] - Over the past four quarters, the company has only beaten consensus EPS estimates once [7] Conclusion - Amprius is viewed as a compelling candidate for an earnings beat, but investors should consider other factors influencing stock performance ahead of the earnings release [8]

FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced it completed a high-volume shipment of SiMaxx™ cells to the Korean Aerospace Research Institute (“KARI”), known as the aeronautics and space agency of South Korea, further strengthening Amprius’ position as the premier global battery solution for HAPS applications. “This partnership with KARI achieves sev ...

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced its schedule for February appearances and activities. Solid-State Batteries: Innovations, Promising Start-Ups, and Future Roadmap Date: February 14-15, 2024 Location: Virtual Event Details: The Solid-State Batteries: Innovations, Promising Start-Ups, and Future Roadmap brings experts together to share resea ...

FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced it has received the prestigious AS9100:2016 certification for its Fremont, CA production facility. This certification, received from Smithers Quality Assessments, Inc., establishes a framework for continual improvement as Amprius continues to supply batteries to the burgeoning electric aviation industry, hel ...

Core Viewpoint - Amprius Technologies (AMPX) has seen a significant stock price increase of 37.7% over the past four weeks, closing at $5, with analysts projecting a potential upside to a mean price target of $11.86, indicating a 137.2% increase from the current price [1] Price Targets and Analyst Consensus - The mean price target is based on seven short-term estimates with a standard deviation of $3.08, suggesting variability in analyst predictions; the lowest estimate is $8 (60% increase), while the highest is $16 (220% increase) [1] - Analysts' price targets can be misleading, as they often set overly optimistic targets influenced by business relationships, which may inflate expectations [3][4] Earnings Estimates and Market Sentiment - There is growing optimism among analysts regarding AMPX's earnings, with a 2.1% increase in the Zacks Consensus Estimate over the past month, indicating a positive trend in earnings estimate revisions [5] - AMPX holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for near-term upside [5] Conclusion on Price Movement - While consensus price targets may not reliably indicate the extent of potential gains, the direction implied by these targets appears to be a useful guide for investors [6]

FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced its all-new SiCoreTM product platform, an expansion of its product portfolio of industry-leading silicon anode batteries targeted to revolutionize electric mobility. In addition to this SiCore product platform, Amprius has also branded its existing silicon nanowire platform SiMaxxTM with its current product ...

In an increasingly wireless world, batteries are becoming more than just the item you forgot to buy on Christmas Eve. They play an essential role in the world’s move to renewable energy. And as investors, there is no shortage of candidates on a list of best battery stocks.  When you think about battery stocks, your first thought may be electric vehicles (EVs). The relationship between the EV stocks and the best battery stocks is symbiotic. Without EVs, many battery manufacturers lose a key source of revenue ...

Core Viewpoint - Five stocks have been added to the Zacks Rank 1 (Strong Buy) List, indicating strong potential for investment based on recent earnings estimate increases. Group 1: Company Summaries - Panasonic Holdings Corporation (PCRFY) has seen a 19.2% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Immunocore Holdings plc (IMCR) has experienced a 6.9% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Catalyst Pharmaceuticals, Inc. (CPRX) has reported a 25.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Amprius Technologies, Inc. (AMPX) has seen an 8.5% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - EnerSys (ENS) has experienced a 7.4% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2]

Table of Contents _______________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________ FORM 10-Q _______________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-04321 AMPRIUS TECHNOLOGIES, INC. ( ...